Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:e1-e11
Published online before print January 3, 2008, doi: 10.1161/CIRCRESAHA.107.167809
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/2/e1    most recent
CIRCRESAHA.107.167809v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navedo, M. F.
Right arrow Articles by Santana, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navedo, M. F.
Right arrow Articles by Santana, L. F.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport
(Circulation Research. 2008;102:e1.)
© 2008 American Heart Association, Inc.


UltraRapid Communications

AKAP150 Is Required for Stuttering Persistent Ca2+ Sparklets and Angiotensin II–Induced Hypertension

Manuel F. Navedo, Madeline Nieves-Cintrón, Gregory C. Amberg, Can Yuan, V. Scott Votaw, W. Jonathan Lederer, G. Stanley McKnight, Luis F. Santana

From the Departments of Physiology & Biophysics (M.F.N., M.N.-C., G.C.A., C.Y., V.S.V., L.F.S.) and Pharmacology (G.S.M.), University of Washington, Seattle; and Medical Biotechnology Center (W.J.L.), University of Maryland Biotechnology Institute, Baltimore. G.C. Amberg is currently with the Department of Biomedical Sciences, Colorado State University, Fort Collins.

Correspondence to Luis F. Santana, Department of Physiology & Biophysics, Box 357290, University of Washington, Seattle, WA 98195. E-mail santana{at}u.washington.edu

Hypertension is a perplexing multiorgan disease involving renal primary pathology and enhanced angiotensin II vascular reactivity. Here, we report that a novel form of a local Ca2+ signaling in arterial smooth muscle is linked to the development of angiotensin II–induced hypertension. Long openings and reopenings of L-type Ca2+ channels in arterial myocytes produce stuttering persistent Ca2+ sparklets that increase Ca2+ influx and vascular tone. These stuttering persistent Ca2+ sparklets arise from the molecular interactions between the L-type Ca2+ channel and protein kinase C{alpha} at only a few subsarcolemmal regions in resistance arteries. We have identified AKAP150 as the key protein, which targets protein kinase C{alpha} to the L-type Ca2+ channels and thereby enables its regulatory function. Accordingly, AKAP150 knockout mice (AKAP150–/–) were found to lack persistent Ca2+ sparklets and have lower arterial wall intracellular calcium ([Ca2+]i) and decreased myogenic tone. Furthermore, AKAP150–/– mice were hypotensive and did not develop angiotensin II–induced hypertension. We conclude that local control of L-type Ca2+ channel function is regulated by AKAP150-targeted protein kinase C{alpha} signaling, which controls stuttering persistent Ca2+ influx, vascular tone, and blood pressure under physiological conditions and underlies angiotensin II–dependent hypertension.


Key Words: L-type Ca2+ channels • protein kinase C • myogenic tone • total internal reflection fluorescence microscopy




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. J. Tunquist, N. Hoshi, E. S. Guire, F. Zhang, K. Mullendorff, L. K. Langeberg, J. Raber, and J. D. Scott
Loss of AKAP150 perturbs distinct neuronal processes in mice
PNAS, August 26, 2008; 105(34): 12557 - 12562.
[Abstract] [Full Text] [PDF]